Abstract

M100907 is an orally active, potent, and highly selective 5-HT2A antagonist with biochemical and pharmacological properties that may provide therapeutic benefit for the treatment of psychosis. The primary objectives of this study are to continue the safety evaluation of M100907 in the treatment of subjects with schizophrenia or schizoaffective disorder who participated in Protocol HMR 3001. The secondary objectives of this study are to: 1) evaluate the long-term efficacy of M100907 as monotherapy for symptom control in subjects with schizophrenia and schizoaffective disorder who participated in Protocol HMR 3001. 2) to continue to evaluate the effects of M100907 on the cognitive deficits associated with schizophrenia and schizoaffective disorder. 3) to assess the impact of M100907 on quality of life scores longitudinally using the Heinrichs-Hanlon-Carpenter Quality of Life Scale (QLS) and the Scale to measure Subjective Well-Being Under Neuroleptic Treatment (SWN). 4) to measure the impact of M100907 resource utilization associated with long-term treatment with M100907. This is a multicenter, long-term, safety follow-up, open-label trial of once-daily dosing of M100907 as monotherapy in the treatment of subjects with schizophrenia or schizoaffective disorder. The GCRC nursing staff will assist with performing EKG's, collecting blood and urine samples, and sample processing.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
2M01RR000080-37
Application #
6264429
Study Section
Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
37
Fiscal Year
1999
Total Cost
Indirect Cost

  Institution

Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106

  Publications

Randis, Tara M; Rice, Madeline Murguia; Myatt, Leslie et al. (2018) Incidence of early-onset sepsis in infants born to women with clinical chorioamnionitis. J Perinat Med 46:926-933
Clark, Erin A S; Weiner, Steven J; Rouse, Dwight J et al. (2018) Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth. Am J Perinatol 35:1012-1022
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Saade, G R; Thom, E A; Grobman, W A et al. (2018) Cervical funneling or intra-amniotic debris and preterm birth in nulliparous women with midtrimester cervical length less than 30 mm. Ultrasound Obstet Gynecol 52:757-762
Inker, Lesley A; Grams, Morgan E; Levey, Andrew S et al. (2018) Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium. Am J Kidney Dis :
Juraschek, Stephen P; Miller 3rd, Edgar R; Appel, Lawrence J (2018) Orthostatic Hypotension and Symptoms in the AASK Trial. Am J Hypertens 31:665-671
Di Fiore, Juliann M; Martin, Richard J; Li, Hong et al. (2017) Patterns of Oxygenation, Mortality, and Growth Status in the Surfactant Positive Pressure and Oxygen Trial Cohort. J Pediatr 186:49-56.e1
Osman, Ahmed Fageer; Thomas, Biju; Singh, Nakul et al. (2017) Impact of Infant-Polysomnography Studies on Discharge Management and Outcomes: A 5 Year Experience from a Tertiary Care Unit. J Neonatal Biol 6:
Tita, Alan T N; Lai, Yinglei; Landon, Mark B et al. (2017) Predictive Characteristics of Elevated 1-Hour Glucose Challenge Test Results for Gestational Diabetes. Am J Perinatol 34:1464-1469
Grams, Morgan E; Yang, Wei; Rebholz, Casey M et al. (2017) Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 70:337-346

Showing the most recent 10 out of 753 publications